NGL Fine-Chem Limited (NSE:NGLFINE)

Lumos Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	5.83	3.95	78.28	6.44	21.03
Short-Term Investments	-	649.45	549.19	446.74	289.05	317.47
Cash & Short-Term Investments	655.28	655.28	553.14	525.03	295.49	338.5
Cash Growth	18.46%	18.46%	5.36%	77.68%	-12.71%	145.13%
Accounts Receivable	-	815.51	896.18	658.71	639.77	375.57
Other Receivables	-	8.15	5.65	2.29	3.45	1.91
Receivables	-	823.65	901.83	661	643.22	377.49
Inventory	-	512.7	433.03	269.93	560.08	378.51
Prepaid Expenses	-	26.82	18.2	17.05	13.85	10.67
Other Current Assets	-	335.34	220.48	153.56	222.29	140.12
Total Current Assets	-	2,354	2,127	1,627	1,735	1,245
Property, Plant & Equipment	-	1,918	1,308	1,139	947.47	759.76
Long-Term Investments	-	10	46.19	43.87	25.69	-
Goodwill	-	1.53	1.53	1.53	1.53	1.53
Other Intangible Assets	-	3.97	1.17	1.73	3.04	3.5
Long-Term Deferred Charges	-	-	-	-	-	0
Other Long-Term Assets	-	46.15	71.6	58.11	56.62	63.81
Total Assets	-	4,334	3,555	2,871	2,769	2,074
Accounts Payable	-	575.18	493.86	245.86	371.55	295.35
Accrued Expenses	-	9.11	6.55	5.59	4.98	4.89
Short-Term Debt	-	478.18	316.98	284.06	234.28	48.32
Current Portion of Long-Term Debt	-	39.44	15.61	20.21	31.38	54.85
Current Income Taxes Payable	-	-	7.21	9.42	0.33	6.48
Other Current Liabilities	-	87.8	25.66	17.78	13.99	7.76
Total Current Liabilities	-	1,190	865.87	582.92	656.5	417.65
Long-Term Debt	-	253.36	7.45	20.73	34.36	61.31
Long-Term Deferred Tax Liabilities	-	24.76	21.94	13.7	19.08	23.78
Other Long-Term Liabilities	-	26.81	21.03	17.48	18.6	18.71
Total Liabilities	-	1,510	929.04	645.3	737.1	529.3
Common Stock	-	30.89	30.89	30.89	30.89	30.89
Additional Paid-In Capital	-	1.17	1.17	1.17	1.17	1.17
Retained Earnings	-	2,781	2,581	2,178	1,985	1,498
Comprehensive Income & Other	-	11.07	13.47	15	15	15
Shareholders' Equity	2,824	2,824	2,626	2,225	2,032	1,545
Total Liabilities & Equity	-	4,334	3,555	2,871	2,769	2,074
Total Debt	770.97	770.97	340.04	324.99	300.02	164.48
Net Cash (Debt)	-115.69	-115.69	213.1	200.03	-4.53	174.02
Net Cash Growth	-	-	6.53%	-	-	-
Net Cash Per Share	-18.73	-18.73	34.49	32.38	-0.73	28.17
Filing Date Shares Outstanding	6.18	6.18	6.18	6.18	6.18	6.18
Total Common Shares Outstanding	6.18	6.18	6.18	6.18	6.18	6.18
Working Capital	-	1,164	1,261	1,044	1,078	827.63
Book Value Per Share	457.16	457.16	425.11	360.23	328.94	250.01
Tangible Book Value	2,819	2,819	2,624	2,222	2,028	1,540
Tangible Book Value Per Share	456.27	456.27	424.67	359.70	328.20	249.20
Land	-	107.1	67.88	45.72	31.29	31.29
Buildings	-	606.13	329.8	329.17	318.72	259.41
Machinery	-	1,441	1,071	1,007	933.95	658.73
Construction In Progress	-	497.26	455.21	263.12	64.32	123.52

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.